A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

Summary

This study aims to assess the safety, tolerability, and pharmacokinetics (PK) of a single oral dose of surotomycin (CB-183,315) at ascending dose levels when given to healthy males and females.

Timeline

Start

2009-01

Primary completion

2009-03

Completion

2009-03

Publications

• Chandorkar G, Zhan Q, Donovan J, Rege S, Patino H. Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers. BMC Pharmacol Toxicol. 2017 Mar 28;18(1):24. doi: 10.1186/s40360-017-0123-z.

Drugs

Indications